decline

NKGen Biotech Administers First Dose of Troculeucel to Alzheimers Patient Who Continued to Decline Cognitively While on Prior Amyloid-Targeting Therapy

July 10, 2025 16:30 ET  | Source: NKGen Biotech, Inc. SANTA ANA, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- NKGen…

5 months ago

IEP – ‘The Great Fragmentation’ Driving Conflict: World Peace Plummets

LONDON, June 18, 2025 /PRNewswire/ -- The 2025 Global Peace Index (GPI), released today by the Institute for Economics &…

6 months ago